Want to identify your GPCR off-target related safety risks?
View in browser
multispan logo
Eblast 1 March 2023 Title

Follow us on Linkedin to receive more updates!

Identify Off-Target Liabilities Early and Discover with Multispan!

• 32-GPCRs with well-defined CNS, cardiac, pulmonary and GI concerns


• Address potential toxicity early to advance the best candidate to market  


• Publication-quality data, shared with control and raw data

 

• Rapid 2-Weeks turnaround

Explore Now!

MULTISCREEN™ 32-GPCR Safety Functional Assay Panel

32-GPCR-Safety-Functional-Assay-Panel-for-Routine-Off-target-Compound-Profiling-1536x916-1
Learn More!

Example Data from Well-Characterized Stable Cell Lines

image2-3-1
Need more information? Email us!

What do our customers say?

 

"Multispan performs GPCR screening for us on a battery of 32 typical targets and off-target GPCRs in drug discovery. What is most impressive about their work product is that they determine functionality (agonist, partial agonist and antagonist) and potency from dose-response curves using multiplexing of assays. After comparison between vendors, we found Multispan to be the least expensive option and to provide the greatest value for the funds we have available. The post-assay customer interface is excellent in that they answer questions and provide relevant commentary as needed."

 

--- Allen Reitz, Ph.D., Chief Executive Officer, Fox Chase Therapeutics Discovery, Inc. 

Screen Shot 2022-07-15 at 6.07.05 pm

info@multispaninc.com

 

www.multispaninc.com

Facebook
LinkedIn
Twitter
YouTube

Multispan, Inc., 26219 Eden Landing Road, Hayward, CA 94545, United States, 510-887-0817

Unsubscribe Manage preferences